What You Should Know:
– Credo Health, a game-changer in value-based care technology, has secured $5.25M in Series Seed funding, led by FCA Venture Partners with strong participation from existing investors Hannah Grey VC, FirstMile Ventures, and SpringTime Ventures. This significant investment fuels Credo’s mission to become the definitive platform for value-based care providers, empowering them to thrive in the evolving healthcare landscape.
Bridging the Data Gap
Credo Health’s core platform, PreDx, stands out by uniquely combining both digital and manual medical record retrieval with cutting-edge AI analysis and human expertise. This powerful combination ensures providers have the complete clinical picture of every patient, eliminating information silos and fostering informed decision-making.
PreDx delivers
- Comprehensive Risk Adjustment: Accurately predict patient needs and optimize reimbursement.
- Enhanced Quality Measures: Achieve top HEDIS scores and drive better healthcare outcomes.
- Personalized Care: Tailor treatment plans to individual patient needs for improved satisfaction.
This funding will enable Credo to strengthen its technological infrastructure and enhance PreDx capabilities and explore new frontiers in AI-powered healthcare.
Credo Founder and CEO, Carm Huntress, is ecstatic about the growth: “This funding validates our commitment to providing value-based care providers with the technology they need to excel. Since launching PreDx at the Vive Conference just nine months ago, we’ve witnessed its transformative impact on organizations, and this investment fuels our expansion to empower even more providers.”
